it

Shaping leaders at the ACS Leadership Institute

Graduate student Safia Jilani shares what she learned from this year's conference




it

AI specialist Atomwise signs with Bridge Biotherapeutics




it

Chemours opens research facility in Delaware




it

Researchers in China report structure of the novel coronavirus bound to its human target

The structure shows the first steps of SARS-CoV-2 infection and could help in drug discovery




it

Thirdhand smoke detected in nonsmoking facility

Tobacco-related compounds probably transported on smokers' clothes and bodies




it

Mechanical chirality gives new shape to catalysis

Mechanically chiral rotaxane creates a catalytic pocket a little like an enzyme




it

How one country is grappling with mercury emissions from artisanal gold shops

Peru seeks to keep rudimentary gold refining from exposing communities to neurotoxic metal




it

How small chemical company leaders are dealing with the coronavirus

Specialty chemical CEOs are rolling with the punches to keep their firms going




it

Air quality improvements boosted California's agriculture industry

Lower ozone levels led to higher grape and almond yields-and decarbonizing the state's economy could provide a further boost




it

Sanofi, Regeneron test arthritis drug against COVID-19

New study explores whether dampening IL-6 could address serious coronavirus infections




it

Podcast: Is it high time for high-throughput experimentation?

Although the concept of HTE, has been around for a while, chemists are increasingly using its microplates and robots to rapidly run myriad experiments simultaneously. <i>Stereo Chemistry</i> explores what's behind the surge in popularity




it

Shortage of RNA extraction kits hampers efforts to ramp up COVID-19 coronavirus testing

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations




it

Chemistry departments deal with coronavirus closures

Amid university shutdowns worldwide, professors and students adjust what social distancing means for lab scientists




it

Stepping up to the hand sanitizer shortage

Chemical companies, breweries, and perfumeries take to making and donating a vital commodity in short supply




it

Ginkgo opens facilities to help COVID-19 coronavirus response

Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines




it

AGC to bolster drug services with MolMed acquisition




it

A chemist enters a popular TV baking competition, and a cat food discovery




it

Finding comets' hidden nitrogen

Ammonium salts may serve as nitrogen reservoirs on the icy bodies, suggesting a common origin for comets and the sun




it

What is hand sanitizer, and does it keep your hands germ-free?

Useful when you don't have access to a sink and some soap, hand sanitizers have become a hot commodity in the face of COVID-19




it

Eliminating catalyst defects boosts activity and extends lifetime

Nearly perfect, long-lasting crystalline catalyst turns CO<sub>2</sub> into valuable products




it

Structure of active ribonucleotide reductase solved with cryo-electron microscopy

Long-awaited image of elusive disordered tail helps scientists better understand the enzyme's mechanism




it

Sumitomo Chemical plans sustainable R&amp;D group




it

Mitsubishi dusts off plan to build US methyl methacrylate plant




it

Shortage of RNA extraction kits hampers efforts to ramp up COVID-19 testing

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations




it

All hands to the sanitizer pump




it

Design Therapeutics launches with $45 million for neurological diseases




it

What can initial remdesivir data tell us about tackling COVID-19?

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts




it

US government allows grant funding flexibility during coronavirus outbreak




it

CAS names its 2020 Future Leaders

Awardees will attend a weeklong program in Columbus in August




it

COVID-19 mostly behind it, China's chemical industry struggles to rev up

Lingering logistic problems and a sputtering economy mean hard times for companies




it

With COVID-19 mostly behind it, China's chemical industry struggles to rev up

Lingering logistic problems and a sputtering economy mean hard times for companies




it

Journal publishers promote flexibility during COVID-19 pandemic

Editors in Europe and the US plan to work with authors whose lives and labs have been disrupted by the novel coronavirus




it

Judge rules Chemours must settle DuPont dispute through arbitration

Chemours plans to appeal the decision to Delaware's Supreme Court




it

CAS curates dataset of antiviral compound leads with potential activity against COVID-19

Open-access collection contains nearly 50,000 chemical compounds from the CAS Registry




it

Covestro borrows $240 million for sustainability R&amp;D




it

Life sciences consortium connects with Gates Foundation to tackle COVID-19




it

Nouryon, Sumitomo form organic peroxide precursor pact




it

Zymergen, Sumitomo launch biobased film for electronics




it

Mitsubishi and Ube widen electrolyte ties




it

Lilly and Sitryx sign immunotherapy pact




it

Arkema plans to exit intermediate chemical businesses




it

3-D printing complex structures with conducting polymers

Procedure for preparing inks for additive manufacturing broadens range of application




it

Combining heat with light boosts methanol synthesis from CO&lt;sub&gt;2&lt;/sub&gt;

Study unravels reaction mechanism occurring on common catalyst




it

Meet Sheng Ding, who is tackling COVID-19 as director of China's Global Health Drug Discovery Institute

The chemist wants the Gates Foundation–backed institute to share its expertise during the coronavirus pandemic and advocate for public health




it

Chemistry faculty cope with coronavirus shutdowns

With university labs shuttered by COVID-19, chemistry faculty are getting a crash course in how to stay productive




it

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease




it

Roche partners with Arrakis on small molecules that target RNA

Arrakis will earn $190 million in its first pharma partnership




it

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease




it

Rgenta Therapeutics launches with $20 million to develop small molecules that target RNA




it

GSK partners with Vir on COVID-19 therapies and with 3 companies on vaccines